CE

CellFiber

3 known investors

cellfiber.jp ↗

CellFiber develops cell mass-production technology for cell and gene therapy, including ZeitoTM Plus, a GMP/GCTP-compliant cell fiber manufacturing device designed for fiber culture that enables aseptic, closed seeding of fiber-encapsulated cells directly into culture bags. It serves the GMP cell manufacturing and cell/gene therapy industry.

Investors · 3

FA

Fast Track InitiativeTokyo · $1.2M – $184M

UN

UntroD CapitalTokyo · $772K – $241M

UN

Universal Materials Incubatorreported